NICORANDIL INCREASES CORONARY BLOOD-FLOW PREDOMINANTLY BY K-CHANNEL OPENING MECHANISM

被引：57

作者：

YONEYAMA, F ^{[1
]}

SATOH, K ^{[1
]}

TAIRA, N ^{[1
]}

机构：

[1] TOHOKU UNIV,SCH MED,DEPT PHARMACOL,2-1 SEIRYO MACHI,SENDAI,MIYAGI 980,JAPAN

来源：

CARDIOVASCULAR DRUGS AND THERAPY | 1990年 / 4卷 / 04期

关键词：

coronary circulation; cromakalim; glibenclamide; K-channel openers; nicorandil; nitroglycerin;

D O I：

10.1007/BF01856508

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Nicorandil has a hybrid property between nitrates and potassium (K)-channel openers. In order to clarify which mechanism of action is responsible for its effect in increasing coronary blood flow, we investigated how this effect was antagonized by glibenclamide, which was recently found to behave as a pharmacologic antagonist of K-channel openers. Cromakalim, one of the most specific K-channel openers currently available, and nitroglycerin were used as reference drugs. In isolated, blood-perfused papillary muscle preparations of dogs, intraarterial injections of nicorandil and cromakalim increased (coronary) blood flow, and at high doses a negative inotropic effect and ventricular fibrillation occurred. Dose-response curves for the increase in coronary blood flow produced by nicorandil or cromakalim were shifted to the right in a parallel manner and to similar extents by glibenclamide given intravenously to support dogs. Schild analysis yielded pA2 values of 6.08 and 6.34 for glibenclamide versus nicorandil and cromakalim, respectively. Nitroglycerin injected intraarterially produced only an increase in coronary blood flow. This effect was not affected by glibenclamide. These results indicate that the effect of nicorandil in increasing coronary blood flow, like that of cromakalim, is predominantly due to its mechanism of action as a K-channel opener. The negative inotropy and ventricular fibrillation seen with high doses of nicroandil and cromakalim were also antagonized by glibenclamide, indicating that these effects are also due to K-channel opening. © 1990 Kluwer Academic Publishers.

引用

页码：1119 / 1126

页数：8

共 25 条

[1] Taira N., Similarity and dissimilarity in the mode and mechanism of action between nicorandil and classical nitrates: An overview, J Cardiovasc Pharmacol, 10, pp. S1-S9, (1987)
[2] Taira N., Nicorandil as a hybrid between nitrates and potassium channel activators, The American Journal of Cardiology, 63, pp. 18J-24J, (1989)
[3] Taira N., Satoh K., Yanagisawa T., Et al., Pharmacological profile of a new coronary vasodilator drug, 2-nicotinamidoethyl nitrate (SG-75), Clin Exp Pharmacol Physiol, 6, pp. 301-316, (1979)
[4] Yanagisawa T., Taira N., Effect of 2-nicotinamidethyl nitrate (SG-75) on the membrane potential of left atrial muscle fibres of the dog. Increase in potassium conductance, Naunyn Schmiedebergs Arch Pharmacol, 312, pp. 69-76, (1980)
[5] Yanagisawa T., Taira N., Effect of 2-nicotinamidethyl nitrate (SG-75) on membrane potentials of canine Purkinje fibers, Jpn J Pharmacol, 31, pp. 409-417, (1981)
[6] Yanagisawa T., Satoh K., Taira N., Circumstantial evidence for increased potassium conductance of membrane of cardiac muscle by 2-nicotinamidoethyl nitrate (SG-75), Jpn J Pharmacol, 29, pp. 687-694, (1979)
[7] Yanagisawa T., Hashimoto H., Taira N., The negative inotropic effect of nicorandil is independent of cyclic GMP changes: A comparison with pinacidil and cromakalim in canine atrial muscle, Br J Pharmacol, 95, pp. 393-398, (1988)
[8] Yanagisawa T., Hashimoto H., Taira N., Interaction of potassium channel openers and blockers in canine atrial muscle, Br J Pharmacol, 97, pp. 753-762, (1989)
[9] Weir S.W., Weston A.H., The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on<sup>86</sup>Rb efflux in rat blood vessels, Br J Pharmacol, 88, pp. 121-128, (1986)
[10] Coldwell M.C., Howlett D.R., Specificity of action of the novel antihypertensive agent, BRL 34915, as a potassium channel activator. Comparison with nicorandil, Biochem Pharmacol, 36, pp. 3663-3669, (1987)

← 1 2 3 →